According to Clarín, following the authorization in the UK, the coronavirus vaccine from the University of Oxford and the pharmaceutical company AstraZeneca has been approved for emergency use in Argentina.

In November, Argentina signed an agreement with the British laboratory for 22.4 million doses. The authorization process at ANMAT had started a month earlier, on October 5. So far, the Argentine health agency has authorized two vaccines against the coronavirus: the Russian Sputnik V, of which 300,000 doses have already begun to be applied to health personnel, and that of Pfizer/BioNTech.

Also according to Clarín, the national Health Minister, Ginés González García, told AM750 radio that in late March or early April “the distribution of AstraZeneca doses begins massively.” And he detailed that the contract is “finished, signed, and partially paid.”